US Edition
Lifecare preps next-gen CGM implant for CE mark submission
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lifecare preps next-gen CGM implant for CE mark submission
A screenshot of the Lifecare implantable CGM technology from a company video. Lifecare announced today that it has formal preparations underway to submit its implantable continuous glucose monitor (CGM) for CE mark. Bergen, Norway-based Lifecare said in a news release that it began its work on CE mark approval six weeks ago. It aims to bring its CGM system to Europe as a regulated medical device by the end of 2026. That includes all components o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
